Source comparison
Melanotan-1 Photoprotection Complete Guide 2026: Comparison Table
Before using any photoprotective strategy, understanding the mechanism, onset, and limitations matters. Melanotan-1 works differently from sunscreen, oral antioxidants, and natural tanning. Melanotan-1 (afamelanotide) MC1R agonism → eumelanin synthesis indepen
This comparison does not assign a generated winner or score.
- Before using any photoprotective strategy, understanding the mechanism, onset, and limitations matters. Melanotan-1 works differently from sunscreen, oral antioxidants, and natural tanning.
- Melanotan-1 (afamelanotide)
- MC1R agonism → eumelanin synthesis independent of UV
- 10–14 days to visible pigmentation; 21–28 days to peak melanin density
- 30–50% reduction in CPD formation; 40% increase in MED
- Requires subcutaneous administration; pigmentation fades over 6–10 weeks; does not eliminate need for sunscreen
- Strongest evidence for pre-emptive photoprotection in fair-skinned individuals; FDA-approved for EPP but used off-label for photoprotection research
- Topical sunscreen (SPF 30–50)
- Physical/chemical UV absorption and reflection at skin surface
- Immediate upon application
- 93–98% UVB blockage (SPF 30); 96–99% UVB blockage (SPF 50)
- Requires reapplication every 2 hours; uneven coverage reduces effectiveness; does not increase melanin density
- Gold standard for acute UV protection; essential even with melanotan-1 use; no systemic photoprotection
- Oral antioxidants (Polypodium leucotomos extract)
- Systemic antioxidant activity reduces oxidative DNA damage post-UV
- 2–4 hours post-ingestion
- 20–30% reduction in erythema and sunburn cell formation in small trials
- Evidence limited to short-term use; does not prevent initial UV absorption; mechanism is damage mitigation, not prevention
- Adjunctive strategy; weaker evidence than melanin-based photoprotection; no pigmentation effect
- Natural UV-induced tanning
- UV radiation → DNA damage → p53 activation → delayed melanin production
- 48–72 hours to visible pigmentation; 2–4 weeks to protective melanin density
- Variable; 15–40% MED increase depending on skin type and cumulative UV dose
- Requires repeated UV damage to build protection; increases lifetime cancer risk; photoaging accelerates
- Least desirable approach for photoprotection. Damage precedes protection; contraindicated for Fitzpatrick I–II